IL-35-Mediated Immunotherapy: A New Treatment for Type I and Autoimmune Diabetes Mellitus

NOV 5, 2024 Researchers has discovered a specific protein IL-35 that protects the immune system by lowering particular immune cells that produce inflammatory chemicals, thereby reducing pancreatic cell infiltration, a key contributor in type 1 diabetes and autoimmune diabetes mellitus. This protein presents a novel diabetes treatment option. […]